Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells.
Otaka
Akira
A
Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Japan. aotaka@pharm.kyoto-u.ac.jp
Nakamura
Miki
M
Nameki
Daisuke
D
Kodama
Eiichi
E
Uchiyama
Susumu
S
Nakamura
Syota
S
Nakano
Hiroaki
H
Tamamura
Hirokazu
H
Kobayashi
Yuji
Y
Matsuoka
Masao
M
Fujii
Nobutaka
N
D000595:Amino Acid Sequence; D019380:Anti-HIV Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D015195:Drug Design; D015700:HIV Envelope Protein gp41 / Q000737:chemistry*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000138:chemical synthesis*; D013329:Structure-Activity Relationship
D019380:Anti-HIV Agents; D015700:HIV Envelope Protein gp41; D010446:Peptide Fragments